|Company Name||Amyris, Inc.|
On March 19, 2019, Amyris announced it was unable to timely file its yearly report for fiscal year ending December 31, 2018, due to “the significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018.” The Company also disclosed that it was “in the process of completing its evaluation of internal control over financial reporting.”
On this news, the Company’s share price fell $0.78, or nearly 20% to close at $3.10 per share on March 20, 2019, thereby injuring investors.
Submit Your Information
If you suffered a loss on your Amyris, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.